Research & Partnership Highlights

(FY22–Present)

Research Pipeline

  • 25 active research projects

  • 4 compounds have translated to Phase I clinical trials

Intellectual Property

  • Over 140 U.S. issued patents

  • More than 350 published patent applications

Collaborations

36 active partnerships with biotech and pharmaceutical companies

* Types include partnered research, co-funded projects, and shared target discovery

Funded Research Projects

35 research initiatives funded since FY22

* Total projected funding exceeds $52 million

Estimated Partnership Costs

Average cost per partnership ranges from $325K to $350K

(all inclusive)

View our Collaborations